pyrazolanthrone has been researched along with Cancer of Larynx in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Chou, KY; Li, Q; Liu, F; Lu, LM; Tao, L; Zhang, D; Zhou, J; Zhou, L | 1 |
Abid, K; Aroui, S; Brahim, S; Kenani, A | 1 |
2 other study(ies) available for pyrazolanthrone and Cancer of Larynx
Article | Year |
---|---|
Low concentrations of trichosanthin induce apoptosis and cell cycle arrest via c-Jun N-terminal protein kinase/mitogen-activated protein kinase activation.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Laryngeal Neoplasms; Protein Kinase Inhibitors; Trichosanthin | 2015 |
Involvement of C-jun NH2-terminal kinase and apoptosis induced factor in apoptosis induced by deglycosylated bleomycin in laryngeal carcinoma cells.
Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Inducing Factor; Bleomycin; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Fas Ligand Protein; Humans; JNK Mitogen-Activated Protein Kinases; Laryngeal Neoplasms; Leukemia; Mitochondria; TNF-Related Apoptosis-Inducing Ligand | 2009 |